Skip to main content
. 2021 Nov 25;17(10):1219–1233. doi: 10.1080/15592294.2021.2003043

Figure 1.

Figure 1.

Study design of discovery experiment.

Legend: CHUB-S7 cells were treated with a range of B12 conditions – Control: B12 – 500 nM, Low B12: B12 – 0.15 nM, No B12: B12 – 0 nM (n = 3) (Figure 1(a)); control and the addition of a methylation inhibitor 5-aza-2'-deoxycytidine (5-Aza-dc) (Figure 1(b))